The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Proinflammatory and Anti-inflammatory Cytokines as Mediators in the Pathogenesis of Septic Shock
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Self-citationA protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
Beutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Processing of tumour necrosis factor-α precursor by metalloproteinases
Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., et al. (1994) · Nature · doi:10.1038/370555a0 · Cited by 1,194
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Hannum, C. H., Wilcox, C. J., Arend, W. P., Joslin, F. G., Dripps, D. J., Heimdal, P. L., Armes, L. G., Sommer, A., Eisenberg, S. P., & Thompson, R. C. (1990) · Nature · doi:10.1038/343336a0 · Cited by 1,122
Kriegler, M., Perez, C., DeFay, K., Albert, I., & Lu, S. D. (1988) · Cell · doi:10.1016/0092-8674(88)90486-2 · Cited by 1,102
Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H., & Thompson, R. C. (1990) · Nature · doi:10.1038/343341a0 · Cited by 1,088
Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome
Casey, L. C., Balk, R. A., & Bone, R. C. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-8-199310150-00001 · Cited by 1,041
Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J., & Dinarello, C. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113431 · Cited by 983
Self-citationInterleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of hsp27
Freshney, N. W., Rawlinson, L., Guesdon, F., Jones, E., Cowley, S., Hsuan, J., & Saklatvala, J. (1994) · Cell · doi:10.1016/0092-8674(94)90278-x · Cited by 864
Van Zee, K. J., Kohno, T., Fischer, E., Rock, C. S., Moldawer, L. L., & Lowry, S. F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4845 · Cited by 845
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C., & Wallach, D. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.323 · Cited by 814
Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects
van der Poll, T., Büller, H. R., ten Cate, H., Wortel, C. H., Bauer, K. A., van Deventer, S. J. H., Hack, C. E., Sauerwein, H. P., Rosenberg, R. D., & ten Cate, J. W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006073222302 · Cited by 667
Fong, Y., Tracey, K. J., Moldawer, L. L., Hesse, D. G., Manogue, K. B., Kenney, J. S., Lee, A. T., Kuo, G. C., Allison, A. C., & Lowry, S. F. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.5.1627 · Cited by 641
Mathison, J. C., Wolfson, E., & Ulevitch, R. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113540 · Cited by 591
Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
Mohler, K. M., Sleath, P. R., Fitzner, J. N., Cerretti, D. P., Alderson, M., Kerwar, S. S., Torranee, D. S., Otten-Evans, C., Greenstreet, T., Weerawarna, K., et al. (1994) · Nature · doi:10.1038/370218a0 · Cited by 588
An Osmosensing Signal Transduction Pathway in Mammalian Cells
Galcheva-Gargova, Z., Dérijard, B., Wu, I.-H., & Davis, R. J. (1994) · Science · doi:10.1126/science.8047888 · Cited by 568
Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor
McGeehan, G. M., Becherer, J. D., Bast, R. C., Boyer, C. M., Champion, B., Connolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., et al. (1994) · Nature · doi:10.1038/370558a0 · Cited by 561
Engelmann, H., Novick, D., & Wallach, D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40049-5 · Cited by 549
Fisher, C. J., Slotman, G. J., Opal, S. M., Pribble, J. P., Bone, R. C., Emmanuel, G., Ng, D., Bloedow, D. C., & Catalano, M. A. (1994) · Critical Care Medicine · doi:10.1097/00003246-199401000-00008 · Cited by 490
Dripps, D. J., Brandhuber, B. J., Thompson, R. C., & Eisenberg, S. P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99230-6 · Cited by 452
Engelmann, H., Aderka, D., Rubinstein, M., Rotman, D., & Wallach, D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80162-4 · Cited by 440
Mathias, S., Younes, A., Kan, C.-C., Orlow, I., Joseph, C., & Kolesnick, R. N. (1993) · Science · doi:10.1126/science.8424175 · Cited by 433
FISHER, C. J., OPAL, S. M., DHAINAUT, J.-F., STEPHENS, S., ZIMMERMAN, J. L., NIGHTINGALE, P., HARRIS, S. J., SCHEIN, R. M. H., PANACEK, E. A., VINCENT, J.-L., et al. (1993) · Critical Care Medicine · doi:10.1097/00003246-199303000-00006 · Cited by 427
Chernoff, A. E., Granowitz, E. V., Shapiro, L., Vannier, E., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Wolff, S. M., & Dinarello, C. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5492 · Cited by 418
Self-citationBeasley, D., Schwartz, J. H., & Brenner, B. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115036 · Cited by 397
Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity.
Engelmann, H., Holtmann, H., Brakebusch, C., Avni, Y. S., Sarov, I., Nophar, Y., Hadas, E., Leitner, O., & Wallach, D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77330-4 · Cited by 378
A urine inhibitor of interleukin 1 activity that blocks ligand binding.
Seckinger, P., Lowenthal, J. W., Williamson, K., Dayer, J. M., & MacDonald, H. R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.5.1546 · Cited by 345
Modulation of cytokine production by transforming growth factor-beta.
Chantry, D., Turner, M., Abney, E., & Feldmann, M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.12.4295 · Cited by 323
Vannier, E., Miller, L. C., & Dinarello, C. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4076 · Cited by 321
Self-citationProduction of interleukin-1-receptor antagonist during experimental endotoxaemia
Granowitz, E. V., Poutsiaka, D. D., Cannon, J. G., Wolff, S. M., Dinarello, C. A., Santos, A. A., & Wilmore, D. W. (1991) · The Lancet · doi:10.1016/0140-6736(91)92725-h · Cited by 310
Self-citationLesslauer, W., Tabuchi, H., Gentz, R., Brockhaus, M., Schlaeger, E. J., Grau, G., Piguet, P. F., Pointaire, P., Vassalli, P., & Loetscher, H. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211134 · Cited by 237
Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients.
Aderka, D., Englemann, H., Hornik, V., Skornick, Y. G., Levo, Y., Wallach, D., & Kushtai, G. (1991) · PubMed · Cited by 233
Administration of Anti-TNF Antibody Improves Left Ventricular Function in Septic Shock Patients
Vincent, J.-L., Bakker, J., Marécaux, G., Schandene, L., Kahn, R. J., & Dupont, E. (1992) · Chest · doi:10.1378/chest.101.3.810 · Cited by 220
Granowitz, E. V., Porat, R., Mier, J. W., Pribble, J. P., Stiles, D. M., Bloedow, D. C., Catalano, M. A., Wolff, S. M., & Dinarello, C. A. (1992) · Cytokine · doi:10.1016/1043-4666(92)90078-6 · Cited by 220
Self-citationInterleukin-1 receptor antagonist circulates in experimental inflammation and in human disease
Fischer, E., Van Zee, K., Marano, M., Rock, C., Kenney, J., Poutsiaka, D., Dinarello, C., Lowry, S., & Moldawer, L. (1992) · Blood · doi:10.1182/blood.v79.9.2196.2196 · Cited by 218
Self-citationClinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer.
Chapman, P. B., Lester, T. J., Casper, E. S., Gabrilove, J. L., Wong, G. Y., Kempin, S. J., Gold, P. J., Welt, S., Warren, R. S., & Starnes, H. F. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.12.1942 · Cited by 214
Interleukin 1 receptor blockade attenuates the host inflammatory response.
Gershenwald, J. E., Fong, Y. M., Fahey, T. J., Calvano, S. E., Chizzonite, R., Kilian, P. L., Lowry, S. F., & Moldawer, L. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.4966 · Cited by 213
Knaus, W. A. (1993) · JAMA · doi:10.1001/jama.270.10.1233 · Cited by 204
Girardin, E. P., Roux-Lombard, P., Grau, G. E., Suter, P. M., Gallati, H., & Dayer, J. (1992) · PubMed Central · Cited by 203
Holtmann, H., & Wallach, D. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.4.1161 · Cited by 177
Dinarello, C. A., Cannon, J. G., Mancilla, J., Bishai, I., Lees, J., & Coceani, F. (1991) · Brain Research · doi:10.1016/0006-8993(91)90622-3 · Cited by 164
Self-citationKunz, D., Mühl, H., Walker, G., & Pfeilschifter, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5387 · Cited by 164
Smith, J. W., Urba, W. J., Curti, B. D., Elwood, L. J., Steis, R. G., Janik, J. E., Sharfman, W. H., Miller, L. L., Fenton, R. G., & Conlon, K. C. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1141 · Cited by 162
Stevenson, F. T., Bursten, S. L., Fanton, C. P., Locksley, R. M., & Lovett, D. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7245 · Cited by 147
Crown, J. P., Jakubowski, A. A., Kemeny, N. E., Gordon, M. S., Gasparetto, C., Wong, G. G., Sheridan, C., Toner, G. C., Meisenberg, B., & Botet, J. F. (1991) · Blood · doi:10.1182/blood.v78.6.1420.1420 · Cited by 142
Effects on leukocytes after injection of tumor necrosis factor into healthy humans
van der Poll, T., van Deventer, S. J. H., Hack, C. E., Wolbink, G., Aarden, L. A., Buller, H. R., & ten Cate, J. W. (1992) · Blood · doi:10.1182/blood.v79.3.693.693 · Cited by 128
Guesdon, F., Freshney, N. W., Waller, R. J., Rawlinson, L. M., & Saklatvala, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53601-2 · Cited by 124
Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues.
Stevenson, F. T., Bursten, S. L., Locksley, R. M., & Lovett, D. H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.1053 · Cited by 117
Cloning of a phospholipase A2-activating protein.
Clark, M. A., Ozgur, L., Conway, T. M., et al. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5418 · Cited by 107
Role of interleukin 1 and tumor necrosis factor on energy metabolism in rabbits
Tredget, E. E., Yu, Y., Zhong, S., Burini, R. C., Okusawa, S., Gelfand, J. A., Dinarello, C. A., Young, V. R., & Burke, J. F. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.255.6.e760 · Cited by 104
Self-citationGronich, J. H., Konieczkowski, M., Gelb, M. H., Nemenoff, R. A., & Sedor, J. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117076 · Cited by 101
Fischer, E., Marano, M. A., Barber, A. E., Hudson, A., Lee, K., Rock, C. S., Hawes, A. S., Thompson, R. C., Hayes, T. J., Anderson, T. D., et al. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.261.2.r442 · Cited by 99
LeMay, L. G., Otterness, I. G., Vander, A. J., & Kluger, M. J. (1990) · Cytokine · doi:10.1016/1043-4666(90)90016-m · Cited by 98
Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor.
Brakebusch, C., Varfolomeev, E. E., Batkin, M., & Wallach, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31661-2 · Cited by 95
Olsson, I., Gatanaga, T., Gullberg, U., Lantz, M., & Granger, G. A. (1993) · PubMed · Cited by 92
Granowitz, E. V., Porat, R., Mier, J. W., Orencole, S. F., Callahan, M., Cannon, J., Lynch, E., Ye, K., Poutsiaka, D., & Vannier, E. G. (1993) · Blood · doi:10.1182/blood.v82.10.2985.2985 · Cited by 84
Aiura, K., Gelfand, J. A., Burke, J. F., Thompson, R. C., & Dinarello, C. A. (1993) · Infection and Immunity · doi:10.1128/iai.61.8.3342-3350.1993 · Cited by 74
Self-citationShapiro, L., Clark, B. D., Orencole, S. F., Poutsiaka, D. D., Granowitz, E. V., & Dinarello, C. A. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1344 · Cited by 61
Self-citationBargetzi, M. J., Lantz, M., Smith, C. G., Torti, F. M., Olsson, I., Eisenberg, S. P., & Starnes, H. F. (1993) · PubMed · Cited by 53
Kracht, M., Truong, O., Totty, N. F., Shiroo, M., & Saklatvala, J. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.6.2017 · Cited by 51
Mandrup-Poulsen, T. R., Wogensen, L., Jensen, M. C., Svensson, P., Nilsson, P., Emdal, T., Mølvig, J., Dinarello, C. A., & Nerup, J. (1995) · Critical Care Medicine · doi:10.1097/00003246-199501000-00008 · Cited by 48
Self-citationChikanza, I. C., Roux-Lombard, P., DAYER, J.-M., & Panayi, G. S. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05941.x · Cited by 47
Tilg, H., Trehu, E., Shapiro, L., Pape, D., Atkins, M. B., Dinarello, C. A., & Mier, J. W. (1994) · Cytokine · doi:10.1016/1043-4666(94)90044-2 · Cited by 38
Self-citationJansen, J., van der Poll, T., Levi, M. M., Cate, H. T., Gallati, H., ten Cate, J. W., & van Deventer, S. J. H. (1995) · Journal of Clinical Immunology · doi:10.1007/bf01489489 · Cited by 35
van der Poll, T., van Deventer, S. J. H., Cate, H. T., Levi, M. M., & ten Cate, J. W. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.3.665 · Cited by 33
Modulation of IL-1 inflammatory and immunomodulatory properties by IL-6.
Hauptmann, B., Damme, J. V., & Dayer, J. (1991) · PubMed · Cited by 33
Hyams, J. S., Fitzgerald, J. E., Wyzga, N., Treem, W. R., Justinich, C. J., & Kreutzer, D. L. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02088122 · Cited by 26
Bertini, R., Delgado, R., Faggioni, R., Gascon, M.-P., Ythier, A., & Ghezzi, P. (1993) · PubMed · Cited by 25
Guesdon, F., Waller, R. J., & Saklatvala, J. (1994) · Biochemical Journal · doi:10.1042/bj3040761 · Cited by 22
Porat, R., Paddock, H. N., Schwaitzberg, S. D., Connolly, R. J., Wilkens, T., Dasch, J. R., Gascon, M.-P., Hutchison, J. S., Ythier, A., Wallach, D., et al. (1995) · Critical Care Medicine · doi:10.1097/00003246-199506000-00014 · Cited by 20
Self-citationClinical Trials of Novel Therapeutic Agents: Why did they fail?
Opal, S. M. (1995) · Yearbook of intensive care and emergency medicine · doi:10.1007/978-3-642-79154-3_34 · Cited by 11
Cited by
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
Schulte, W., Bernhagen, J., & Bucala, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/165974 · Cited by 745
Mira, J.-P., Cariou, A., Grall, F., Delclaux, C., Losser, M.-R., Heshmati, F., Cheval, C., Monchi, M., Teboul, J.-L., Riché, F., et al. (1999) · JAMA · doi:10.1001/jama.282.6.561 · Cited by 740
Greten, F. R., Arkan, M. C., Bollrath, J., Hsu, L.-C., Goode, J., Miething, C., Göktuna, S. I., Neuenhahn, M., Fierer, J., Paxian, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.009 · Cited by 616
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614
Metadata
- Authors
- Dinarello, C. A.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1997-12
- Volume
- 112
- Issue
- 6
- Pages
- 321S-329S
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2014748042
- Cited by
- 508
- References
- 78
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.